{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T10:26:13Z","timestamp":1779877573343,"version":"3.53.1"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1005943","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T00:00:00Z","timestamp":1518048000000}}],"reference-count":70,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2018,1,29]],"date-time":"2018-01-29T00:00:00Z","timestamp":1517184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["2010-200"],"award-info":[{"award-number":["2010-200"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["2011-SIMI7"],"award-info":[{"award-number":["2011-SIMI7"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1005943","type":"journal-article","created":{"date-parts":[[2018,1,29]],"date-time":"2018-01-29T18:24:04Z","timestamp":1517250244000},"page":"e1005943","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":27,"title":["Identification of allosteric inhibitors of the ecto-5'-nucleotidase (CD73) targeting the dimer interface"],"prefix":"10.1371","volume":"14","author":[{"given":"Rahila","family":"Rahimova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Fontanel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6348-5311","authenticated-orcid":true,"given":"Corinne","family":"Lionne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars Peter","family":"Jordheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Peyrottes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5757-5804","authenticated-orcid":true,"given":"Laurent","family":"Chaloin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,1,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion","volume":"331","author":"RD Schreiber","year":"2011","journal-title":"Science"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s11302-013-9372-5","article-title":"Purinergic signalling and cancer","volume":"9","author":"G Burnstock","year":"2013","journal-title":"Purinergic Signal"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/nrc3613","article-title":"Immunity, inflammation and cancer: a leading role for adenosine","volume":"13","author":"L Antonioli","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/imr.12528","article-title":"The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets","volume":"276","author":"B Allard","year":"2017","journal-title":"Immunol Rev"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1084\/jem.20062512","article-title":"Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression","volume":"204","author":"S Deaglio","year":"2007","journal-title":"J Exp Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.coph.2016.04.001","article-title":"Immunosuppressive activities of adenosine in cancer","volume":"29","author":"B Allard","year":"2016","journal-title":"Curr Opin Pharmacol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0163-7258(00)00053-X","article-title":"Tumor-promoting functions of adenosine","volume":"87","author":"J Spychala","year":"2000","journal-title":"Pharmacol Ther"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"13132","DOI":"10.1073\/pnas.0605251103","article-title":"A2A adenosine receptor protects tumors from antitumor T cells","volume":"103","author":"A Ohta","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl 1","key":"ref9","doi-asserted-by":"crossref","first-page":"S457","DOI":"10.1038\/bjp.2008.23","article-title":"Adenosine A2A receptor antagonists: blockade of adenosinergic effects and T regulatory cells","volume":"153","author":"M Sitkovsky","year":"2008","journal-title":"Br J Pharmacol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1042\/bj2850345","article-title":"5'-Nucleotidase: molecular structure and functional aspects","volume":"285","author":"H Zimmermann","year":"1992","journal-title":"Biochem J"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1600-065X.1998.tb01574.x","article-title":"Ecto-enzyme and signaling functions of lymphocyte CD73","volume":"161","author":"R Resta","year":"1998","journal-title":"Immunol Rev"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2217\/imt.15.106","article-title":"CD73-adenosine: a next-generation target in immuno-oncology","volume":"8","author":"D Allard","year":"2016","journal-title":"Immunotherapy"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.trecan.2016.01.003","article-title":"Anti-CD73 in cancer immunotherapy: awakening new opportunities","volume":"2","author":"L Antonioli","year":"2016","journal-title":"Trends Cancer"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"4494","DOI":"10.1158\/0008-5472.CAN-14-3569","article-title":"CD73 is associated with poor prognosis in high-grade serous ovarian cancer","volume":"75","author":"M Turcotte","year":"2015","journal-title":"Cancer Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1172\/JCI79380","article-title":"Loss of CD73-mediated actin polymerization promotes endometrial tumor progression","volume":"126","author":"JL Bowser","year":"2016","journal-title":"J Clin Invest"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/PAI.0b013e3182311d82","article-title":"CD73 expression as a potential marker of good prognosis in breast carcinoma","volume":"20","author":"A Supernat","year":"2012","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"ref17","article-title":"Levels and enzyme activity of CD73 in primary samples from cancer patients","volume":"75","author":"QH Huang","year":"2015","journal-title":"Cancer Research"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1097\/CCM.0000000000000550","article-title":"Early prediction of persistent organ failure by soluble CD73 in patients with acute pancreatitis*","volume":"42","author":"M Maksimow","year":"2014","journal-title":"Crit Care Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00432-007-0292-z","article-title":"Ecto-5'-nucleotidase promotes invasion, migration and adhesion of human breast cancer cells","volume":"134","author":"L Wang","year":"2008","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"426","DOI":"10.4161\/cbt.6.3.3762","article-title":"Overexpression of Ecto-5'-nucleotidase (CD73) promotes T-47D human breast cancer cells invasion and adhesion to extracellular matrix","volume":"6","author":"P Zhou","year":"2007","journal-title":"Cancer Biol Ther"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1158\/2159-8290.CD-14-0341","article-title":"Targeting cancer-derived adenosine: new therapeutic approaches","volume":"4","author":"A Young","year":"2014","journal-title":"Cancer Discov"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1158\/0008-5472.CAN-12-0420","article-title":"CD73-deficient mice are resistant to carcinogenesis","volume":"72","author":"J Stagg","year":"2012","journal-title":"Cancer Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1158\/0008-5472.CAN-10-4246","article-title":"CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasis","volume":"71","author":"J Stagg","year":"2011","journal-title":"Cancer Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1073\/pnas.0908801107","article-title":"Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis","volume":"107","author":"J Stagg","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10585-007-9081-y","article-title":"RNA interference of ecto-5'-nucleotidase (CD73) inhibits human breast cancer cell growth and invasion","volume":"24","author":"X Zhi","year":"2007","journal-title":"Clin Exp Metastasis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"6248","DOI":"10.1021\/acs.jmedchem.5b00802","article-title":"alpha,beta-Methylene-ADP (AOPCP) Derivatives and Analogues: Development of Potent and Selective ecto-5'-Nucleotidase (CD73) Inhibitors","volume":"58","author":"S Bhattarai","year":"2015","journal-title":"J Med Chem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.tips.2012.03.005","article-title":"Structural approaches to obtain kinase selectivity","volume":"33","author":"RA Norman","year":"2012","journal-title":"Trends Pharmacol Sci"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/nbt.1990","article-title":"Comprehensive analysis of kinase inhibitor selectivity","volume":"29","author":"MI Davis","year":"2011","journal-title":"Nat Biotechnol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1080\/19420862.2016.1143182","article-title":"Inhibition of CD73 AMP hydrolysis by a therapeutic antibody with a dual, non-competitive mechanism of action","volume":"8","author":"JC Geoghegan","year":"2016","journal-title":"MAbs"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.str.2012.10.001","article-title":"Crystal structure of the human ecto-5'-nucleotidase (CD73): insights into the regulation of purinergic signaling","volume":"20","author":"K Knapp","year":"2012","journal-title":"Structure"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1002\/cbic.201200426","article-title":"Crystal structure of a soluble form of human CD73 with ecto-5'-nucleotidase activity","volume":"13","author":"DP Heuts","year":"2012","journal-title":"Chembiochem"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1021\/jm100574m","article-title":"Understanding and predicting druggability. A high-throughput method for detection of drug binding sites","volume":"53","author":"P Schmidtke","year":"2010","journal-title":"J Med Chem"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nrd1467","article-title":"Fragment-based lead discovery","volume":"3","author":"DC Rees","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S1359-6446(04)03069-7","article-title":"Ligand efficiency: a useful metric for lead selection","volume":"9","author":"AL Hopkins","year":"2004","journal-title":"Drug Discov Today"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/j.ddtec.2010.11.003","article-title":"Ligand efficiency as a guide in fragment hit selection and optimization","volume":"7","author":"S Schultes","year":"2010","journal-title":"Drug Discov Today: Technologies"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1158\/1535-7163.MCT-16-0205","article-title":"Novel p21-Activated Kinase 4 (PAK4) Allosteric Modulators Overcome Drug Resistance and Stemness in Pancreatic Ductal Adenocarcinoma","volume":"16","author":"A Aboukameel","year":"2017","journal-title":"Mol Cancer Ther"},{"key":"ref37","article-title":"The small GTPases K-Ras, N-Ras and H-Ras have distinct biochemical properties determined by allosteric effects","author":"CW Johnson","year":"2017","journal-title":"J Biol Chem"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0022-2836(65)80285-6","article-title":"On the Nature of Allosteric Transitions: A Plausible Model","volume":"12","author":"J Monod","year":"1965","journal-title":"J Mol Biol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.cell.2016.08.015","article-title":"Allosteric Modulation as a Unifying Mechanism for Receptor Function and Regulation","volume":"166","author":"JP Changeux","year":"2016","journal-title":"Cell"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"e0178678","DOI":"10.1371\/journal.pone.0178678","article-title":"Designing small molecules to target cryptic pockets yields both positive and negative allosteric modulators","volume":"12","author":"KM Hart","year":"2017","journal-title":"PLoS One"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jmb.2011.02.059","article-title":"Structural Basis for the Allosteric Regulation and Substrate Recognition of Human Cytosolic 5'-Nucleotidase II","volume":"408","author":"K Wallden","year":"2011","journal-title":"J Mol Biol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"18759","DOI":"10.1016\/S0021-9258(18)37348-4","article-title":"High Km soluble 5'-nucleotidase from human placenta. Properties and allosteric regulation by IMP and ATP","volume":"263","author":"J Spychala","year":"1988","journal-title":"J Biol Chem"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1021\/acs.molpharmaceut.7b00275","article-title":"Toward Successful Cyclodextrin Based Solubility-Enabling Formulations for Oral Delivery of Lipophilic Drugs: Solubility-Permeability Trade-Off, Biorelevant Dissolution, and the Unstirred Water Layer","volume":"14","author":"N Fine-Shamir","year":"2017","journal-title":"Mol Pharm"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"e0150877","DOI":"10.1371\/journal.pone.0150877","article-title":"beta-Cyclodextrin-Based Inclusion Complexation Bridged Biodegradable Self-Assembly Macromolecular Micelle for the Delivery of Paclitaxel","volume":"11","author":"Y Chen","year":"2016","journal-title":"PLoS One"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.drudis.2012.08.004","article-title":"Oral delivery of anticancer drugs I: general considerations","volume":"18","author":"S Mazzaferro","year":"2013","journal-title":"Drug Discov Today"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.addr.2009.07.019","article-title":"Chitosan-based hydrogels for controlled, localized drug delivery","volume":"62","author":"N Bhattarai","year":"2010","journal-title":"Adv Drug Deliv Rev"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/cbdv.200590082","article-title":"Nucleolipids: natural occurrence, synthesis, molecular recognition, and supramolecular assemblies as potential precursors of life and bioorganic materials","volume":"2","author":"H Rosemeyer","year":"2005","journal-title":"Chem Biodivers"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ejmech.2012.06.044","article-title":"Synthesis, self-aggregation and bioactivity properties of a cationic aminoacyl surfactant, based on a new class of highly functionalized nucleolipids","volume":"57","author":"L Simeone","year":"2012","journal-title":"Eur J Med Chem"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.tips.2005.01.008","article-title":"Interfacial inhibition of macromolecular interactions: nature's paradigm for drug discovery","volume":"26","author":"Y Pommier","year":"2005","journal-title":"Trends Pharmacol Sci"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1021\/jm901851t","article-title":"Development of potent and selective inhibitors of ecto-5'-nucleotidase based on an anthraquinone scaffold","volume":"53","author":"Y Baqi","year":"2010","journal-title":"J Med Chem"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"6576","DOI":"10.1021\/jm300658n","article-title":"Virtual screening identifies novel sulfonamide inhibitors of ecto-5'-nucleotidase","volume":"55","author":"P Ripphausen","year":"2012","journal-title":"J Med Chem"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ejmech.2013.10.053","article-title":"Identification of sulfonic acids as efficient ecto-5'-nucleotidase inhibitors","volume":"70","author":"J Iqbal","year":"2013","journal-title":"Eur J Med Chem"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/med.21302","article-title":"Therapeutic potentials of ecto-nucleoside triphosphate diphosphohydrolase, ecto-nucleotide pyrophosphatase\/phosphodiesterase, ecto-5'-nucleotidase, and alkaline phosphatase inhibitors","volume":"34","author":"M Al-Rashida","year":"2014","journal-title":"Med Res Rev"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/jcc.20289","article-title":"Scalable molecular dynamics with NAMD","volume":"26","author":"JC Phillips","year":"2005","journal-title":"J Comput Chem"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1063\/1.467468","article-title":"Constant pressure molecular dynamics algorithms","volume":"101","author":"GJ Martyna","year":"1994","journal-title":"J Chem Phys"},{"key":"ref56","first-page":"4613","article-title":"Constant pressure molecular dynamics simulation-the langevin piston method","volume":"103","author":"SE Feller","year":"1995","journal-title":"J Comput Chem"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/wcms.74","article-title":"Recent Developments and Applications of the CHARMM force fields","volume":"2","author":"X Zhu","year":"2012","journal-title":"Wiley Interdiscip Rev Comput Mol Sci"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"8577","DOI":"10.1063\/1.470117","article-title":"A Smooth Particle Mesh Ewald Method","volume":"103","author":"U Essmann","year":"1995","journal-title":"Journal of Chemical Physics"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1093\/bioinformatics\/btr550","article-title":"MDpocket: open-source cavity detection and characterization on molecular dynamics trajectories","volume":"27","author":"P Schmidtke","year":"2011","journal-title":"Bioinformatics"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/1471-2105-10-168","article-title":"Fpocket: an open source platform for ligand pocket detection","volume":"10","author":"V Le Guilloux","year":"2009","journal-title":"BMC Bioinformatics"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"W407","DOI":"10.1093\/nar\/gkm290","article-title":"ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins","volume":"35","author":"M Wiederstein","year":"2007","journal-title":"Nucleic acids research"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/prot.10286","article-title":"Structure validation by Calpha geometry: phi,psi and Cbeta deviation","volume":"50","author":"SC Lovell","year":"2003","journal-title":"Proteins"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: An open chemical toolbox","volume":"3","author":"NM O'Boyle","year":"2011","journal-title":"J Cheminform"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/jcc.23214","article-title":"Message passing interface and multithreading hybrid for parallel molecular docking of large databases on petascale high performance computing machines","volume":"34","author":"X Zhang","year":"2013","journal-title":"J Comput Chem"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"O Trott","year":"2010","journal-title":"J Comput Chem"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","article-title":"Development and validation of a genetic algorithm for flexible docking","volume":"267","author":"G Jones","year":"1997","journal-title":"J Mol Biol"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"W Humphrey","year":"1996","journal-title":"J Mol Graph"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"5980","DOI":"10.1016\/j.bmcl.2013.08.029","article-title":"Setting expectations in molecular optimizations: Strengths and limitations of commonly used composite parameters","volume":"23","author":"MD Shultz","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1359-6446(05)03386-6","article-title":"Ligand efficiency indices as guideposts for drug discovery","volume":"10","author":"C Abad-Zapatero","year":"2005","journal-title":"Drug Discov Today"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0888-7543(88)90107-3","article-title":"Molecular analysis of the cDNA for human SPARC\/osteonectin\/BM-40: sequence, expression, and localization of the gene to chromosome 5q31-q33","volume":"2","author":"A Swaroop","year":"1988","journal-title":"Genomics"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1005943","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T00:00:00Z","timestamp":1518048000000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1005943","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T20:03:01Z","timestamp":1719777781000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1005943"}},"subtitle":[],"editor":[{"given":"Avner","family":"Schlessinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,1,29]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1005943","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pcbi.1005943","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,29]]}}}